Igor Lifirenko
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
- Neutropenia and Cancer Infections 1
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Gábor Répássy (1 shared paper)Per Soelberg Sørensen (1 shared paper)Tina Nielsen (1 shared paper)Paul M. Clément (1 shared paper)Jean-Pascal Machiels (1 shared paper)Ágnes Ruzsa (1 shared paper)Steen Lisby (1 shared paper)Francisco J. Esteva (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- RussiaPolandSouth Korea
In The Last Decade
Igor Lifirenko
4 papers receiving 177 citations
Peers
Comparison fields: 5 of 33
- Otorhinolaryngology 96
- Oncology 118
- Pulmonary and Respiratory Medicine 83
- Immunology 22
- Radiology, Nuclear Medicine and Imaging 22
Countries citing papers authored by Igor Lifirenko
This map shows the geographic impact of Igor Lifirenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Lifirenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Lifirenko more than expected).
Fields of papers citing papers by Igor Lifirenko
This network shows the impact of papers produced by Igor Lifirenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Lifirenko. The network helps show where Igor Lifirenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Lifirenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 163 | |
| 2 | 2017 | 9 | |
| 3 | 2015 | 5 | |
| 4 | 2017 | 5 |
About Igor Lifirenko
Igor Lifirenko is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Surgery and Otorhinolaryngology, having authored 4 papers that have together received 182 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (2 papers), HER2/EGFR in Cancer Research (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Treatment and Pharmacology (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Salivary Gland Tumors Diagnosis and Treatment (1 paper), Fungal Infections and Studies (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Otorhinolaryngology (96 citations), Oncology (118 citations), Pulmonary and Respiratory Medicine (83 citations), Immunology (22 citations) and Radiology, Nuclear Medicine and Imaging (22 citations). Igor Lifirenko has collaborated with scholars based in Russia, Poland and South Korea. Frequent co-authors include Gábor Répássy, Per Soelberg Sørensen, Tina Nielsen, Paul M. Clément, Jean-Pascal Machiels, Ágnes Ruzsa, Steen Lisby, Francisco J. Esteva, Daniil Stroyakovskiy and Andriy Rusyn. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.